What is the Historic and Current Scenario of the Pharmaceutical Excipients Market?
The pharmaceutical excipients market has seen considerable growth due to a variety of factors.
• In recent years, the market size of pharmaceutical excipients has seen substantial growth. The market, which was valued at $10257.72 billion in 2024, is projected to increase to $10926.17 billion in 2025, maintaining a compound annual growth rate (CAGR) of 6.5%.
The historical growth can be credited to significant economic expansion in developing markets, a spike in the sales of generic drugs, and a steadily improving advanced healthcare infrastructure.
How Does the Forecast Look for the Pharmaceutical Excipients Market?
The pharmaceutical excipients market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of pharmaceutical excipients is predicted to witness notable growth in the upcoming years, rising to $14263.02 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%.
This surge in the forecast period can be accounted for by government schemes, the proliferation of novel drug development, escalating healthcare spending, and the swift increase in the aging population, all of which contribute to market expansion. Major trends anticipated during the forecast period encompass emphasis on eco-friendly packing to minimize the use of plastic, strategic mergers and acquisitions to solidify market standing, commitment to cut down greenhouse gas output, and the use of artificial intelligence to monitor nutrients, water quantities and enhance transparency in supply chains.
What Are The Key Drivers Fueling Growth In The Pharmaceutical Excipients Market?
The worldwide increase in generic drug sales has stimulated the expansion of the pharmaceutical excipients market. These generic drugs serve as substitutes for branded drugs with the same dosage, safety parameters, potency, administration method, and superior quality. As per the India Brand Equity Foundation (IBEF), India leads in the provision of generic medicines, with the nation's generic drugs constituting 20% of global generic drugs exports. Indian pharmaceutical firms achieved 300 generic drug approvals in the USA, underlining an increase in demand for these drugs and pushing growth in the pharmaceutical excipients market.
How Are The Segments Defined Within The Global Pharmaceutical Excipients Market?
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
Pre-Book The Pharmaceutical Excipients Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Pharmaceutical Excipients Market?
Leading firms in the pharmaceutical excipient market are rolling out innovative excipients such as high-purity excipients to bolster drug formulation stability, elevate bioavailability, and facilitate intricate drug delivery systems. High-purity excipients are pharmaceutical excipients that have been treated by sophisticated purification procedures to eradicate impurities and pollutants. Clariant, a Swiss-based specialty chemical firm, for example, in October 2023, unveiled three new VitiPure excipients specifically created to boost the stability and solubility of active pharmaceutical ingredients (APIs). These products are VitiPure O 80 Superior - a top-quality polysorbate 80, VitiPure CO 35 Superior - a polyoxyl 35 castor oil, and VitiPure Meglumine LEX - a solubilizer characterized by low bioburden. These excipients, developed for a range of drug delivery applications particularly for delicate formulations such as mRNA vaccines and biologics, address the increasing need for high-purity ingredients and comply with rigorous regulatory norms.
Who Are the Key Players in the Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipients market include:
• BASF SE
• Ashland Global Holdings
• Evonik Industries AG
• International Flavors & Fragrances. Inc
• Roquette Frères
• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International Plc
• Kerry Group
• DuPont de Nemours. Inc.
• Sun Pharmaceuticals Industries Ltd
• Cipla Ltd
• Amster Microcell Private Limited
• Finar Limited
• P. D. Polychem Private Limited
• CAD Pharma Inc
• Maas Pharma Chemicals
• Aeon Procare Private Limited
• CSPC Pharmaceutical Group Ltd
• Allen & Hanburys Ltd
• Actelion Pharmaceuticals UK Ltd
• Colorcon
• MEGGLE GmbH & Co. KG
• Boehringer Ingelheim International GmbH
• DMV-Fonterra Excipients GmbH & Co. KG
• Alpen Pharma AG
• Avantor Inc
• JRS PHARMA GmbH & Co. KG
• The Dow Chemical Co
• Pfizer
• AbbVie Inc
• EMS Pharma
• Biolab Farmaceutica
• Medist FZE
• W.R. Grace
• Univar Solutions
• Nitika Pharma
• DFE Pharma
• Cargill
• Sensient Pharma
What Is The Most Dominant Region In The Pharmaceutical Excipients Market?
North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
